aluates Reports

$ 0.0

Automative

Global Molecular Oncology Market Research Report 2026

Published Date: 2026-01-29

Report Code: QYRE-Auto-5L18435

Global Molecular Oncology Market Research Report 2024

BUY CHAPTERS

Global Molecular Oncology Market Research Report 2026

Code: QYRE-Auto-5L18435

Report

2026-01-29

Pages:102

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche Diagnostics

Thermo Fisher Scientific Inc

Illumina Inc

QIAGEN N V

Agilent Technologies Inc

Abbott Laboratories

Bio-Rad Laboratories Inc

Myriad Genetics Inc

Genomic Health Inc.

Molecular Oncology Market

The global Molecular Oncology market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Molecular diagnostics in cancer is becoming more and more common in clinical laboratories. Targeted therapy possibilities for malignancies such as multiple myeloma, lymphoma, melanoma, lung, breast, ovarian, prostate, and others are now being assessed using molecular oncology assays.Molecular oncology researchers use a variety of methods, including as in-vitro and in vivo functional models, computational biology, genomics, and tumor imaging, to comprehend biological and clinical characteristics.The genes that produce these proteins may be used as targets in the development of novel anti-cancer medications, chemotherapeutic medicines, or imaging scans. These combinatorial methods are used in molecular oncology to confirm the involvement of novel candidate genes in the genesis of cancer.

The North American market for Molecular Oncology is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Molecular Oncology is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Molecular Oncology in Hospitals and Clinics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Molecular Oncology include Roche Diagnostics, Thermo Fisher Scientific Inc., Illumina, Inc., Qiagen N.V., Agilent Technologies, Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Myriad Genetics, Inc., Genomic Health, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Molecular Oncology market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Molecular Oncology. The Molecular Oncology market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Molecular Oncology market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Molecular Oncology manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Molecular Oncology Market Report

Report Metric	Details
Report Name	Molecular Oncology Market
Segment by Type	PCR NGS (Next Generation Sequencing) Microarray FISH (Fluorescent in situ-hybridization) Others
Segment by Application	Hospitals and Clinics Diagnostic Laboratories Cancer Centers and Specialty Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche Diagnostics, Thermo Fisher Scientific Inc., Illumina, Inc., Qiagen N.V., Agilent Technologies, Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Myriad Genetics, Inc., Genomic Health, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Molecular Oncology companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Molecular Oncology Market report?

Ans: The main players in the Molecular Oncology Market are Roche Diagnostics, Thermo Fisher Scientific Inc., Illumina, Inc., Qiagen N.V., Agilent Technologies, Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Myriad Genetics, Inc., Genomic Health, Inc.

What are the Application segmentation covered in the Molecular Oncology Market report?

Ans: The Applications covered in the Molecular Oncology Market report are Hospitals and Clinics, Diagnostic Laboratories, Cancer Centers and Specialty Clinics, Others

What are the Type segmentation covered in the Molecular Oncology Market report?

Ans: The Types covered in the Molecular Oncology Market report are PCR, NGS (Next Generation Sequencing), Microarray, FISH (Fluorescent in situ-hybridization), Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Molecular Oncology Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 PCR

1.2.3 NGS (Next Generation Sequencing)

1.2.4 Microarray

1.2.5 FISH (Fluorescent in situ-hybridization)

1.2.6 Others

1.3 Market by Application

1.3.1 Global Molecular Oncology Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals and Clinics

1.3.3 Diagnostic Laboratories

1.3.4 Cancer Centers and Specialty Clinics

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Molecular Oncology Market Perspective (2021–2032)

2.2 Global Molecular Oncology Growth Trends by Region

2.2.1 Global Molecular Oncology Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Molecular Oncology Historic Market Size by Region (2021–2026)

2.2.3 Molecular Oncology Forecasted Market Size by Region (2027–2032)

2.3 Molecular Oncology Market Dynamics

2.3.1 Molecular Oncology Industry Trends

2.3.2 Molecular Oncology Market Drivers

2.3.3 Molecular Oncology Market Challenges

2.3.4 Molecular Oncology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Molecular Oncology Players by Revenue

3.1.1 Global Top Molecular Oncology Players by Revenue (2021–2026)

3.1.2 Global Molecular Oncology Revenue Market Share by Players (2021–2026)

3.2 Global Top Molecular Oncology Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Molecular Oncology Revenue

3.4 Global Molecular Oncology Market Concentration Ratio

3.4.1 Global Molecular Oncology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Molecular Oncology Revenue in 2025

3.5 Global Key Players of Molecular Oncology Head Offices and Areas Served

3.6 Global Key Players of Molecular Oncology, Products and Applications

3.7 Global Key Players of Molecular Oncology, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Molecular Oncology Breakdown Data by Type

4.1 Global Molecular Oncology Historic Market Size by Type (2021–2026)

4.2 Global Molecular Oncology Forecasted Market Size by Type (2027–2032)

5 Molecular Oncology Breakdown Data by Application

5.1 Global Molecular Oncology Historic Market Size by Application (2021–2026)

5.2 Global Molecular Oncology Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Molecular Oncology Market Size (2021–2032)

6.2 North America Molecular Oncology Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Molecular Oncology Market Size by Country (2021–2026)

6.4 North America Molecular Oncology Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Molecular Oncology Market Size (2021–2032)

7.2 Europe Molecular Oncology Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Molecular Oncology Market Size by Country (2021–2026)

7.4 Europe Molecular Oncology Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Molecular Oncology Market Size (2021–2032)

8.2 Asia-Pacific Molecular Oncology Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Molecular Oncology Market Size by Region (2021–2026)

8.4 Asia-Pacific Molecular Oncology Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Molecular Oncology Market Size (2021–2032)

9.2 Latin America Molecular Oncology Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Molecular Oncology Market Size by Country (2021–2026)

9.4 Latin America Molecular Oncology Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Molecular Oncology Market Size (2021–2032)

10.2 Middle East & Africa Molecular Oncology Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Molecular Oncology Market Size by Country (2021–2026)

10.4 Middle East & Africa Molecular Oncology Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche Diagnostics

11.1.1 Roche Diagnostics Company Details

11.1.2 Roche Diagnostics Business Overview

11.1.3 Roche Diagnostics Molecular Oncology Introduction

11.1.4 Roche Diagnostics Revenue in Molecular Oncology Business (2021–2026)

11.1.5 Roche Diagnostics Recent Development

11.2 Thermo Fisher Scientific Inc.

11.2.1 Thermo Fisher Scientific Inc. Company Details

11.2.2 Thermo Fisher Scientific Inc. Business Overview

11.2.3 Thermo Fisher Scientific Inc. Molecular Oncology Introduction

11.2.4 Thermo Fisher Scientific Inc. Revenue in Molecular Oncology Business (2021–2026)

11.2.5 Thermo Fisher Scientific Inc. Recent Development

11.3 Illumina, Inc.

11.3.1 Illumina, Inc. Company Details

11.3.2 Illumina, Inc. Business Overview

11.3.3 Illumina, Inc. Molecular Oncology Introduction

11.3.4 Illumina, Inc. Revenue in Molecular Oncology Business (2021–2026)

11.3.5 Illumina, Inc. Recent Development

11.4 Qiagen N.V.

11.4.1 Qiagen N.V. Company Details

11.4.2 Qiagen N.V. Business Overview

11.4.3 Qiagen N.V. Molecular Oncology Introduction

11.4.4 Qiagen N.V. Revenue in Molecular Oncology Business (2021–2026)

11.4.5 Qiagen N.V. Recent Development

11.5 Agilent Technologies, Inc.

11.5.1 Agilent Technologies, Inc. Company Details

11.5.2 Agilent Technologies, Inc. Business Overview

11.5.3 Agilent Technologies, Inc. Molecular Oncology Introduction

11.5.4 Agilent Technologies, Inc. Revenue in Molecular Oncology Business (2021–2026)

11.5.5 Agilent Technologies, Inc. Recent Development

11.6 Abbott Laboratories

11.6.1 Abbott Laboratories Company Details

11.6.2 Abbott Laboratories Business Overview

11.6.3 Abbott Laboratories Molecular Oncology Introduction

11.6.4 Abbott Laboratories Revenue in Molecular Oncology Business (2021–2026)

11.6.5 Abbott Laboratories Recent Development

11.7 Bio-Rad Laboratories, Inc.

11.7.1 Bio-Rad Laboratories, Inc. Company Details

11.7.2 Bio-Rad Laboratories, Inc. Business Overview

11.7.3 Bio-Rad Laboratories, Inc. Molecular Oncology Introduction

11.7.4 Bio-Rad Laboratories, Inc. Revenue in Molecular Oncology Business (2021–2026)

11.7.5 Bio-Rad Laboratories, Inc. Recent Development

11.8 Myriad Genetics, Inc.

11.8.1 Myriad Genetics, Inc. Company Details

11.8.2 Myriad Genetics, Inc. Business Overview

11.8.3 Myriad Genetics, Inc. Molecular Oncology Introduction

11.8.4 Myriad Genetics, Inc. Revenue in Molecular Oncology Business (2021–2026)

11.8.5 Myriad Genetics, Inc. Recent Development

11.9 Genomic Health, Inc.

11.9.1 Genomic Health, Inc. Company Details

11.9.2 Genomic Health, Inc. Business Overview

11.9.3 Genomic Health, Inc. Molecular Oncology Introduction

11.9.4 Genomic Health, Inc. Revenue in Molecular Oncology Business (2021–2026)

11.9.5 Genomic Health, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche Diagnostics

Thermo Fisher Scientific Inc

Illumina Inc

QIAGEN N V

Agilent Technologies Inc

Abbott Laboratories

Bio-Rad Laboratories Inc

Myriad Genetics Inc

Genomic Health Inc.

List of Tables

Table 1. Global Molecular Oncology Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of PCR

Table 3. Key Players of NGS (Next Generation Sequencing)

Table 4. Key Players of Microarray

Table 5. Key Players of FISH (Fluorescent in situ-hybridization)

Table 6. Key Players of Others

Table 7. Global Molecular Oncology Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Molecular Oncology Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Molecular Oncology Market Size by Region (US$ Million), 2021–2026

Table 10. Global Molecular Oncology Market Share by Region (2021–2026)

Table 11. Global Molecular Oncology Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Molecular Oncology Market Share by Region (2027–2032)

Table 13. Molecular Oncology Market Trends

Table 14. Molecular Oncology Market Drivers

Table 15. Molecular Oncology Market Challenges

Table 16. Molecular Oncology Market Restraints

Table 17. Global Molecular Oncology Revenue by Players (US$ Million), 2021–2026

Table 18. Global Molecular Oncology Market Share by Players (2021–2026)

Table 19. Global Top Molecular Oncology Players by Tier (Tier 1, Tier 2, and Tier 3), based on Molecular Oncology Revenue, 2025

Table 20. Ranking of Global Top Molecular Oncology Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Molecular Oncology Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Molecular Oncology, Headquarters and Area Served

Table 23. Global Key Players of Molecular Oncology, Products and Applications

Table 24. Global Key Players of Molecular Oncology, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Molecular Oncology Market Size by Type (US$ Million), 2021–2026

Table 27. Global Molecular Oncology Revenue Market Share by Type (2021–2026)

Table 28. Global Molecular Oncology Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Molecular Oncology Revenue Market Share by Type (2027–2032)

Table 30. Global Molecular Oncology Market Size by Application (US$ Million), 2021–2026

Table 31. Global Molecular Oncology Revenue Market Share by Application (2021–2026)

Table 32. Global Molecular Oncology Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Molecular Oncology Revenue Market Share by Application (2027–2032)

Table 34. North America Molecular Oncology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Molecular Oncology Market Size by Country (US$ Million), 2021–2026

Table 36. North America Molecular Oncology Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Molecular Oncology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Molecular Oncology Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Molecular Oncology Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Molecular Oncology Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Molecular Oncology Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Molecular Oncology Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Molecular Oncology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Molecular Oncology Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Molecular Oncology Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Molecular Oncology Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Molecular Oncology Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Molecular Oncology Market Size by Country (US$ Million), 2027–2032

Table 49. Roche Diagnostics Company Details

Table 50. Roche Diagnostics Business Overview

Table 51. Roche Diagnostics Molecular Oncology Product

Table 52. Roche Diagnostics Revenue in Molecular Oncology Business (US$ Million), 2021–2026

Table 53. Roche Diagnostics Recent Development

Table 54. Thermo Fisher Scientific Inc. Company Details

Table 55. Thermo Fisher Scientific Inc. Business Overview

Table 56. Thermo Fisher Scientific Inc. Molecular Oncology Product

Table 57. Thermo Fisher Scientific Inc. Revenue in Molecular Oncology Business (US$ Million), 2021–2026

Table 58. Thermo Fisher Scientific Inc. Recent Development

Table 59. Illumina, Inc. Company Details

Table 60. Illumina, Inc. Business Overview

Table 61. Illumina, Inc. Molecular Oncology Product

Table 62. Illumina, Inc. Revenue in Molecular Oncology Business (US$ Million), 2021–2026

Table 63. Illumina, Inc. Recent Development

Table 64. Qiagen N.V. Company Details

Table 65. Qiagen N.V. Business Overview

Table 66. Qiagen N.V. Molecular Oncology Product

Table 67. Qiagen N.V. Revenue in Molecular Oncology Business (US$ Million), 2021–2026

Table 68. Qiagen N.V. Recent Development

Table 69. Agilent Technologies, Inc. Company Details

Table 70. Agilent Technologies, Inc. Business Overview

Table 71. Agilent Technologies, Inc. Molecular Oncology Product

Table 72. Agilent Technologies, Inc. Revenue in Molecular Oncology Business (US$ Million), 2021–2026

Table 73. Agilent Technologies, Inc. Recent Development

Table 74. Abbott Laboratories Company Details

Table 75. Abbott Laboratories Business Overview

Table 76. Abbott Laboratories Molecular Oncology Product

Table 77. Abbott Laboratories Revenue in Molecular Oncology Business (US$ Million), 2021–2026

Table 78. Abbott Laboratories Recent Development

Table 79. Bio-Rad Laboratories, Inc. Company Details

Table 80. Bio-Rad Laboratories, Inc. Business Overview

Table 81. Bio-Rad Laboratories, Inc. Molecular Oncology Product

Table 82. Bio-Rad Laboratories, Inc. Revenue in Molecular Oncology Business (US$ Million), 2021–2026

Table 83. Bio-Rad Laboratories, Inc. Recent Development

Table 84. Myriad Genetics, Inc. Company Details

Table 85. Myriad Genetics, Inc. Business Overview

Table 86. Myriad Genetics, Inc. Molecular Oncology Product

Table 87. Myriad Genetics, Inc. Revenue in Molecular Oncology Business (US$ Million), 2021–2026

Table 88. Myriad Genetics, Inc. Recent Development

Table 89. Genomic Health, Inc. Company Details

Table 90. Genomic Health, Inc. Business Overview

Table 91. Genomic Health, Inc. Molecular Oncology Product

Table 92. Genomic Health, Inc. Revenue in Molecular Oncology Business (US$ Million), 2021–2026

Table 93. Genomic Health, Inc. Recent Development

Table 94. Research Programs/Design for This Report

Table 95. Key Data Information from Secondary Sources

Table 96. Key Data Information from Primary Sources

Table 97. Authors List of This Report

List of Figures

Figure 1. Molecular Oncology Picture

Figure 2. Global Molecular Oncology Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Molecular Oncology Market Share by Type: 2025 vs 2032

Figure 4. PCR Features

Figure 5. NGS (Next Generation Sequencing) Features

Figure 6. Microarray Features

Figure 7. FISH (Fluorescent in situ-hybridization) Features

Figure 8. Others Features

Figure 9. Global Molecular Oncology Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Molecular Oncology Market Share by Application: 2025 vs 2032

Figure 11. Hospitals and Clinics Case Studies

Figure 12. Diagnostic Laboratories Case Studies

Figure 13. Cancer Centers and Specialty Clinics Case Studies

Figure 14. Others Case Studies

Figure 15. Molecular Oncology Report Years Considered

Figure 16. Global Molecular Oncology Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 17. Global Molecular Oncology Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 18. Global Molecular Oncology Market Share by Region: 2025 vs 2032

Figure 19. Global Molecular Oncology Market Share by Players in 2025

Figure 20. Global Molecular Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. The Top 10 and 5 Players Market Share by Molecular Oncology Revenue in 2025

Figure 22. North America Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. North America Molecular Oncology Market Share by Country (2021–2032)

Figure 24. United States Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Canada Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Molecular Oncology Market Share by Country (2021–2032)

Figure 28. Germany Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. France Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. U.K. Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Italy Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Russia Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Ireland Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Molecular Oncology Market Share by Region (2021–2032)

Figure 36. China Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Japan Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. South Korea Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Southeast Asia Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. India Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Australia & New Zealand Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Molecular Oncology Market Share by Country (2021–2032)

Figure 44. Mexico Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Brazil Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Molecular Oncology Market Share by Country (2021–2032)

Figure 48. Israel Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Saudi Arabia Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. UAE Molecular Oncology Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Roche Diagnostics Revenue Growth Rate in Molecular Oncology Business (2021–2026)

Figure 52. Thermo Fisher Scientific Inc. Revenue Growth Rate in Molecular Oncology Business (2021–2026)

Figure 53. Illumina, Inc. Revenue Growth Rate in Molecular Oncology Business (2021–2026)

Figure 54. Qiagen N.V. Revenue Growth Rate in Molecular Oncology Business (2021–2026)

Figure 55. Agilent Technologies, Inc. Revenue Growth Rate in Molecular Oncology Business (2021–2026)

Figure 56. Abbott Laboratories Revenue Growth Rate in Molecular Oncology Business (2021–2026)

Figure 57. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Molecular Oncology Business (2021–2026)

Figure 58. Myriad Genetics, Inc. Revenue Growth Rate in Molecular Oncology Business (2021–2026)

Figure 59. Genomic Health, Inc. Revenue Growth Rate in Molecular Oncology Business (2021–2026)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Molecular Diagnostics Cancer Market Insights Forecast to 2030

Molecular Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oncology Based Molecular Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ovarian Cancer Molecular Diagnostics Market Research Report 2024

Global Oncology Small Molecule Drugs Market Insights Forecast to 2030

Global Small Molecule Targeted Cancer Therapy Market Research Report 2025

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

Global Hematology Oncology Diagnostics Market Research Report 2024

Global Molecular Breast Imaging Market Research Report 2024

Global Prostate Cancer Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnosis of Testicular Cancer Market Research Report 2024

Global Colorectal Cancer Molecular Diagnostics Market Research Report 2024

Molecular Targeted Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Oncology Drugs Market Research Report 2024

Global Lymphoma Molecular Diagnostics Market Research Report 2024

Global Kidney Cancer Molecular Diagnostics Market Research Report 2024

Global Personalized Medicines In Oncology Market Research Report 2024

Global Chest Cancer Molecular Diagnostics Market Research Report 2024

Global Lung Cancer Molecular Diagnostics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions